iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Dublin, Dec. 23, 2016 -- Research and Markets has announced the addition of the "Glioblastoma Drugs Price Analysis and Strategies - 2016" report to their offering.
Glioblastoma Drugs Price Analysis and Strategies 2016, provides drug pricing data and benchmarks in the global Glioblastoma market.
The research answers the following questions:
- What are the key drugs marketed for Glioblastoma and their clinical attributes? How are they positioned in the Global Glioblastoma market?
- What are the unit prices and annual treatment cost for Glioblastoma therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
- What are the unmet needs in the global Glioblastoma drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Glioblastoma?
Research Scope:
- Treatment Options - Identify key drugs marketed and prescribed for Glioblastoma including trade name, molecule name, and company
- Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Glioblastoma
- Market Positioning - Identify how drugs are clinically and commercially positioned in the global Glioblastoma market
- Glioblastoma Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed
- Find out how the price advanced from 2012 and forecast to 2021
- Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape
- Glioblastoma New Drug Pricing - Identify the effective pricing strategy for a new drug launch
Key Topics Covered:
1. Treatment Options
2. Drugs Clinical Attributes
3. Drugs Market Positioning
4. Drugs Price Analysis
5. Drugs Price Benchmarks
6. Drug Pricing & Reimbursement Landscape
7. Drugs Price Forecast
8. Market Unmet Needs
9. New Drug Pricing
For more information about this report visit http://www.researchandmarkets.com/research/9kxxzk/glioblastoma
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Brain Cancer Drugs
